HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katsuhiko Shirahige Selected Research

De Lange Syndrome (Cornelia De Lange Syndrome)

1/2019Cornelia de Lange syndrome, related disorders, and the Cohesin complex: Abstracts from the 8th biennial scientific and educational symposium 2018.
5/2017Cornelia de Lange syndrome and molecular implications of the cohesin complex: Abstracts from the 7th biennial scientific and educational symposium 2016.
1/2017Decreased cohesin in the brain leads to defective synapse development and anxiety-related behavior.
6/2015Clinical, developmental and molecular update on Cornelia de Lange syndrome and the cohesin complex: abstracts from the 2014 Scientific and Educational Symposium.
6/2014Cornelia de Lange syndrome: further delineation of phenotype, cohesin biology and educational focus, 5th Biennial Scientific and Educational Symposium abstracts.
9/2012HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle.
10/2010A direct role for cohesin in gene regulation and ecdysone response in Drosophila salivary glands.
9/2010Genome-wide DNA methylation analysis in cohesin mutant human cell lines.
5/2009Transcriptional dysregulation in NIPBL and cohesin mutant human cells.
2/2008Cohesin mediates transcriptional insulation by CCCTC-binding factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katsuhiko Shirahige Research Topics

Disease

10De Lange Syndrome (Cornelia De Lange Syndrome)
01/2019 - 02/2008
9Neoplasms (Cancer)
01/2022 - 02/2007
4Carcinoma (Carcinomatosis)
06/2022 - 02/2007
4Genomic Instability
11/2018 - 06/2014
3Carcinogenesis
01/2022 - 01/2016
3Colonic Neoplasms (Colon Cancer)
01/2019 - 01/2016
3Chromosomal Instability (Chromosome Stability)
01/2017 - 04/2002
2Glioblastoma (Glioblastoma Multiforme)
10/2021 - 10/2014
2Infections
06/2021 - 03/2016
2Aneuploidy (Aneuploid)
01/2020 - 04/2002
2Prostatic Neoplasms (Prostate Cancer)
08/2015 - 01/2009
2T-Cell Lymphoma (Lymphoma, T Cell)
03/2014 - 11/2012
2Neuroblastoma
01/2014 - 11/2012
2Chromosome Duplication
03/2011 - 01/2007
2Starvation
12/2008 - 06/2005
1Ovarian Epithelial Carcinoma
06/2022
1Ovarian Neoplasms (Ovarian Cancer)
02/2022
1Virus Diseases (Viral Diseases)
06/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
03/2021
1Fibrosis (Cirrhosis)
03/2021
1Arthritis (Polyarthritis)
01/2021
1Rheumatoid Arthritis
01/2021
1Necrosis
01/2021
1Osteoarthritis
01/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020
1Neoplasm Metastasis (Metastasis)
01/2019
1Hypertension (High Blood Pressure)
10/2018
1Stroke (Strokes)
10/2018
1Pathologic Processes
11/2016
1Colorectal Neoplasms (Colorectal Cancer)
11/2016
1Micrognathism
08/2016
1Dwarfism
08/2016
1Bacterial Infections (Bacterial Infection)
10/2015
1Breast Neoplasms (Breast Cancer)
06/2014
1Facies
06/2014
1Atherosclerosis
05/2009
1Dyslipidemias (Dyslipidemia)
05/2009
1Isochromosomes
11/2008

Drug/Important Bio-Agent (IBA)

17CohesinsIBA
06/2021 - 02/2008
11Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2005
8ChromatinIBA
06/2021 - 02/2007
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2004
4Transcription Factors (Transcription Factor)IBA
11/2016 - 01/2009
3Phosphotransferases (Kinase)IBA
10/2015 - 12/2008
2Phosphates (Orthophosphate)IBA
06/2022 - 12/2008
2InterferonsIBA
03/2021 - 01/2021
2Pharmaceutical PreparationsIBA
01/2021 - 01/2018
2Long Noncoding RNAIBA
01/2019 - 11/2016
2Biological ProductsIBA
01/2018 - 11/2016
2CateninsIBA
11/2016 - 01/2016
2Histones (Histone)IBA
10/2015 - 01/2009
2Androgen Receptors (Androgen Receptor)IBA
08/2015 - 01/2009
2AntibodiesIBA
08/2015 - 01/2009
2AndrogensIBA
08/2015 - 01/2009
2Rad51 RecombinaseIBA
06/2014 - 11/2008
1Biomarkers (Surrogate Marker)IBA
02/2022
116S Ribosomal RNAIBA
02/2022
1RNA Helicases (RNA Helicase)IBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1RNA Splicing FactorsIBA
01/2022
1Small Cytoplasmic RNAIBA
10/2021
1MethyltransferasesIBA
06/2021
1Viral ProteinsIBA
06/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1CytokinesIBA
01/2021
1Untranslated RNA (Noncoding RNA)IBA
01/2021
1InterleukinsIBA
01/2021
1ChemokinesIBA
01/2021
1RNA Polymerase II (RNA Polymerase B)IBA
01/2020
1CalicIBA
01/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1Heterogeneous-Nuclear Ribonucleoprotein LIBA
01/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019
1Replication Protein C (Replication Factor C)IBA
11/2018
1SaltsIBA
10/2018
1EP1 Subtype Prostaglandin E ReceptorsIBA
10/2018
1Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2017
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2017
1Transcription Factor 3IBA
11/2016
1Coat Protein Complex I (COPI)IBA
08/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
03/2016
1LigandsIBA
03/2016
1Heterogeneous-Nuclear Ribonucleoprotein KIBA
01/2016
1LipopolysaccharidesIBA
10/2015
1Ubiquitin-Specific ProteasesIBA
08/2015
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
08/2015
1Deubiquitinating EnzymesIBA
08/2015
1SphingolipidsIBA
07/2015
15-hydroxymethylcytosineIBA
10/2014
1N- hydroxy- 3- (1- (phenylthio)methyl- 1H- 1,2,3- triazol- 4- yl)benzamideIBA
03/2014
1condensin complexes (condensin)IBA
01/2014
1Antimitotic AgentsIBA
11/2010
1PoisonsIBA
11/2010
1ApolipoproteinsIBA
05/2009
1Apolipoprotein A-I (Apolipoprotein A1)IBA
05/2009
1MetriboloneIBA
01/2009
1Hormones (Hormone)IBA
01/2009
1Amyloid (Amyloid Fibrils)IBA
01/2009

Therapy/Procedure

2Drug Therapy (Chemotherapy)
06/2022 - 04/2022
2Therapeutics
01/2022 - 08/2015